The JSE was slightly weaker on Monday morning, with its global peers mixed as prospects for a pick up in economic growth contended with concerns over a number of risks.
US equities climbed on Friday after news that a new oral antiviral treatment for Covid-19 from Merck — a US multinational pharmaceutical company — reduced the risk of hospitalisation or death by 50% for patients with mild or moderate cases. The company disclosed plans to seek emergency authorisation for the treatment...
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: